Heart failure after myocardial infarction: incidence and predictors

• Main Authors: Dominik Jenča, Vojtěch Melenovský, Josef Stehlik, Vladimír Staněk, Jiří Kettner, Josef Kautzner, Věra Adámková, Peter Wohlfahrt
• Format: Article
• Language: English
• Published: Wiley 2021-02-01
• Series: ESC Heart Failure
• Subjects: Heart failure; Clinical risk factors; Biomarkers; Genetics; Adverse remodelling
• Online Access: https://doi.org/10.1002/ehf2.13144

Abstract Aims The aim of the present paper was to provide an up‐to‐date view on epidemiology and risk factors of heart failure (HF) development after myocardial infarction. Methods and results Based on literature review, several clinical risk factors and biochemical, genetic, and imaging biomarkers were identified to predict the risk of HF development after myocardial infarction. Conclusions Heart failure is still a frequent complication of myocardial infarction. Timely identification of subjects at risk for HF development using a multimodality approach, and early initiation of guideline‐directed HF therapy in these patients, can decrease the HF burden.